A password will be e-mailed to you.

Aurora Cannabis continues to remained disciplined and committed to long-term growth. The company should be analyzed based upon how deals and decisions impact medical cannabis segment. Looking at how all the pieces fit together is what represents the value of Aurora. Why looking for it to act like Canopy Growth isn’t a good idea. Based upon a lot of commentary I hear about a number of deals and decisions management of Aurora Cannabis (ACB) has made, it’s apparent many pundits and commentators base much of their outlook on what the general impact on the performance of the company will be in the short term, rather than the value of acquisitions and partnerships over the long haul. As a matter of fact, many times what it doesn’t do is more important than what it does. Aurora Cannabis’ Commitment To The Long Game A Huge Competitive Advantage

thumbnail courtesy of seekingalpha.com